Susquehanna International Group’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 7030 |
|
|
2025
Q1 | – | Sell |
-67,054
| Closed | -$178K | – | 6947 |
|
|
2024
Q4 | $178K | Buy |
67,054
+24,831
| +59% | +$65.8K | ﹤0.01% | 5384 |
|
|
2024
Q3 | $76.8K | Sell |
42,223
-53,895
| -56% | -$98.1K | ﹤0.01% | 5193 |
|
|
2024
Q2 | $160K | Sell |
96,118
-44,033
| -31% | -$73.1K | ﹤0.01% | 4884 |
|
|
2024
Q1 | $318K | Buy |
140,151
+126,184
| +903% | +$286K | ﹤0.01% | 4106 |
|
|
2023
Q4 | $27.7K | Sell |
13,967
-26,643
| -66% | -$52.8K | ﹤0.01% | 5631 |
|
|
2023
Q3 | $52.8K | Buy |
+40,610
| New | +$52.8K | ﹤0.01% | 5104 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6294 |
|
|
2023
Q1 | – | Sell |
-164,821
| Closed | -$610K | – | 6540 |
|
|
2022
Q4 | $610K | Buy |
+164,821
| New | +$610K | ﹤0.01% | 2930 |
|
|
2022
Q3 | – | Sell |
-39,565
| Closed | -$31K | – | 6727 |
|
|
2022
Q2 | $31K | Buy |
+39,565
| New | +$31K | ﹤0.01% | 5336 |
|
|
2022
Q1 | – | Sell |
-38,609
| Closed | -$309K | – | 6352 |
|
|
2021
Q4 | $309K | Sell |
38,609
-89,657
| -70% | -$718K | ﹤0.01% | 4458 |
|
|
2021
Q3 | $1.07M | Buy |
128,266
+85,407
| +199% | +$715K | ﹤0.01% | 2670 |
|
|
2021
Q2 | $289K | Sell |
42,859
-21,399
| -33% | -$144K | ﹤0.01% | 4492 |
|
|
2021
Q1 | $425K | Buy |
+64,258
| New | +$425K | ﹤0.01% | 4016 |
|
|
2020
Q3 | – | Sell |
-11,501
| Closed | -$70K | – | 4853 |
|
|
2020
Q2 | $70K | Sell |
11,501
-1,257
| -10% | -$7.65K | ﹤0.01% | 3978 |
|
|
2020
Q1 | $70K | Sell |
12,758
-3,990
| -24% | -$21.9K | ﹤0.01% | 4131 |
|
|
2019
Q4 | $166K | Buy |
+16,748
| New | +$166K | ﹤0.01% | 3564 |
|
|
2018
Q2 | – | Sell |
-15,905
| Closed | -$49K | – | 4457 |
|
|
2018
Q1 | $49K | Sell |
15,905
-13,980
| -47% | -$43.1K | ﹤0.01% | 3122 |
|
|
2017
Q4 | $96K | Buy |
+29,885
| New | +$96K | ﹤0.01% | 3336 |
|